Risk, reward and the AstraZeneca vaccine
People in the UK under 30 will be offered an alternative to the AstraZeneca vaccine because of a possible link to rare blood clots. Could the move dent confidence in the widely used jab?. Help support our independent journalism at theguardian.com/infocus
